Ligne de temps
Damien Batalie
Technicien(ne)
02 avr. 2024
publication
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
Lire plus01 janv. 2022
publication
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.
Lire plus01 sept. 2021
publication
Discovery of genes that modulate flavivirus replication in an interferon-dependent manner
Lire plus01 janv. 2021
publication
Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents – The-ANRS-EP59-CLEAC Study.
Lire plus16 juil. 2015
16 juil. 2015
11 mai 2015